Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Chen

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Clinical and Translational Science|February 14, 2022
Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC-0214 in healthy volunteersRui Zhu, Hubert Chen, Joshua Galanter, et al.
The Journal of Allergy and Clinical Immunology|March 21, 2021
Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trialIrene E Braithwaite, Fang Cai, Jennifer A Tom, et al.
The New England Journal of Medicine|December 14, 2022
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis BullosaShireen V Guide, Mercedes E Gonzalez, I Sinem Bağcı, et al.
Critical Care Medicine|December 15, 2022
Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 TrialMichael Waters, James A McKinnell, Andre C Kalil, et al.
Pulmonary Pharmacology & Therapeutics|June 1, 2022
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammationHubert Chen, Rebecca Kunder, Yixuan Zou, et al.
Critical Care (London, England)|June 13, 2023
Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsisCarrie M Rosenberger, Katherine D Wick, Hanjing Zhuo, et al.
Scientific Reports|April 3, 2022
A whole genome sequencing study of moderate to severe asthma identifies a lung function locus associated with asthma riskDiana Chang, Julie Hunkapiller, Tushar Bhangale, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical and Translational Science|February 14, 2022
Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC-0214 in healthy volunteersRui Zhu, Hubert Chen, Joshua Galanter, et al.
The Journal of Allergy and Clinical Immunology|March 21, 2021
Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trialIrene E Braithwaite, Fang Cai, Jennifer A Tom, et al.
The New England Journal of Medicine|December 14, 2022
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis BullosaShireen V Guide, Mercedes E Gonzalez, I Sinem Bağcı, et al.
Critical Care Medicine|December 15, 2022
Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 TrialMichael Waters, James A McKinnell, Andre C Kalil, et al.
Pulmonary Pharmacology & Therapeutics|June 1, 2022
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammationHubert Chen, Rebecca Kunder, Yixuan Zou, et al.
Critical Care (London, England)|June 13, 2023
Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsisCarrie M Rosenberger, Katherine D Wick, Hanjing Zhuo, et al.
Scientific Reports|April 3, 2022
A whole genome sequencing study of moderate to severe asthma identifies a lung function locus associated with asthma riskDiana Chang, Julie Hunkapiller, Tushar Bhangale, et al.
Pageof 6